| Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization D Planas, D Veyer, A Baidaliuk, I Staropoli, F Guivel-Benhassine, ... Nature 596 (7871), 276-280, 2021 | 2135 | 2021 |
| Considerable escape of SARS-CoV-2 Omicron to antibody neutralization D Planas, N Saunders, P Maes, F Guivel-Benhassine, C Planchais, ... Nature 602 (7898), 671-675, 2022 | 1378 | 2022 |
| Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study A Sáez-Cirión, C Bacchus, L Hocqueloux, V Avettand-Fenoel, I Girault, ... PLoS pathogens 9 (3), e1003211, 2013 | 1156 | 2013 |
| Dolutegravir plus abacavir–lamivudine for the treatment of HIV-1 infection SL Walmsley, A Antela, N Clumeck, D Duiculescu, A Eberhard, ... New England Journal of Medicine 369 (19), 1807-1818, 2013 | 1017 | 2013 |
| Sensitivity of infectious SARS-CoV-2 B. 1.1. 7 and B. 1.351 variants to neutralizing antibodies D Planas, T Bruel, L Grzelak, F Guivel-Benhassine, I Staropoli, F Porrot, ... Nature medicine 27 (5), 917-924, 2021 | 733 | 2021 |
| Dolutegravir in antiretroviral-experienced patients with raltegravir-and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study A Castagna, F Maggiolo, G Penco, D Wright, A Mills, R Grossberg, ... The Journal of infectious diseases 210 (3), 354-362, 2014 | 420 | 2014 |
| Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts L Hocqueloux, V Avettand-Fenoël, S Jacquot, T Prazuck, E Legac, ... Journal of Antimicrobial Chemotherapy 68 (5), 1169-1178, 2013 | 285 | 2013 |
| The clinical spectrum of severe imported falciparum malaria in the intensive care unit: report of 188 cases in adults F Bruneel, L Hocqueloux, C Alberti, M Wolff, S Chevret, JP Bédos, ... American journal of respiratory and critical care medicine 167 (5), 684-689, 2003 | 272 | 2003 |
| Serum neutralization of SARS-CoV-2 Omicron sublineages BA. 1 and BA. 2 in patients receiving monoclonal antibodies T Bruel, J Hadjadj, P Maes, D Planas, A Seve, I Staropoli, ... Nature medicine 28 (6), 1297-1302, 2022 | 270 | 2022 |
| Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection L Hocqueloux, T Prazuck, V Avettand-Fenoel, A Lafeuillade, B Cardon, ... Aids 24 (10), 1598-1601, 2010 | 245 | 2010 |
| Total HIV-1 DNA, a marker of viral reservoir dynamics with clinical implications V Avettand-Fènoël, L Hocqueloux, J Ghosn, A Cheret, P Frange, A Melard, ... Clinical microbiology reviews 29 (4), 859-880, 2016 | 223 | 2016 |
| Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation Y Chen, C Scieux, V Garrait, G Socié, V Rocha, JM Molina, D Thouvenot, ... Clinical Infectious Diseases 31 (4), 927-935, 2000 | 198 | 2000 |
| Resistance of Omicron subvariants BA. 2.75. 2, BA. 4.6, and BQ. 1.1 to neutralizing antibodies D Planas, T Bruel, I Staropoli, F Guivel-Benhassine, F Porrot, P Maes, ... Nature communications 14 (1), 824, 2023 | 137 | 2023 |
| Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission A Cheret, C Bacchus-Souffan, V Avettand-Fenoël, A Mélard, G Nembot, ... Journal of Antimicrobial Chemotherapy 70 (7), 2108-2120, 2015 | 120 | 2015 |
| Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy L Hocqueloux, F Agbalika, E Oksenhendler, JM Molina Aids 15 (2), 280-282, 2001 | 119 | 2001 |
| Barriers to access to care reported by women living with HIV across 27 countries M Johnson, A Samarina, H Xi, J Valdez Ramalho Madruga, L Hocqueloux, ... AIDS care 27 (10), 1220-1230, 2015 | 106 | 2015 |
| Reduced sensitivity of infectious SARS-CoV-2 variant B. 1.617. 2 to monoclonal antibodies and sera from convalescent and vaccinated individuals D Planas, D Veyer, A Baidaliuk, I Staropoli, F Guivel-Benhassine, ... Biorxiv, 2021.05. 26.445838, 2021 | 102 | 2021 |
| Bone infection in cat-scratch disease: a review of the literature N Hajjaji, L Hocqueloux, R Kerdraon, L Bret Journal of Infection 54 (5), 417-421, 2007 | 98 | 2007 |
| Considerable escape of SARS-CoV-2 variant Omicron to antibody neutralization D Planas, N Saunders, P Maes, F Guivel-Benhassine, C Planchais, ... BioRxiv, 2021.12. 14.472630, 2021 | 92 | 2021 |
| Dolutegravir (DTG; S/GSK1349572)+ abacavir/lamivudine once daily statistically superior to tenofovir/emtricitabine/efavirenz: 48-week results—SINGLE (ING114467) S Walmsley, A Antela, N Clumeck, D Duiculescu, A Eberhard, F Gutierrez, ... 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy 9 (9 …, 2012 | 92 | 2012 |
